Replies to post #375778 on NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

Yes, LP, LG and the lot could agree not hold all options and warrants for a period of time which would de-risk the over-allotment. It would allow time to make whatever deal they are exploring. IMO, going it alone would be a LP ego play and not a benefit to GBM patients. There is no scenario where I see the treatment getting to patients faster going it alone. Partnerships are a possibility, but again, a longer road and less value to shareholders, IMO. A buyout is the best for patients and shareholders, IMO. And the "comments" from DI stating they are working towards the best outcome for patients and shareholders points me in the buyout direction.

[flipper44]

Sometimes what large pharma companies seem to allow is for a small company to uplist and raise its price by a certain amount after (or concurrent with) TLD in order that the inevitable buyout offer becomes a more reasonable premium. It just seems to work out like that. Here, it seems NWBO and/or BP(s) willingly shackled NWBO’s price per share until such time that irrefutable proof is presented. Thus you have DI actually saying the price per share got ahead of itself when it rose to 2.50. Obviously, the shackles were still on then, and clearly appear to remain for now. IMHO that’s the only thing that makes sense when DI actually frowns on price per share increase early on in his stint at NWBO.

[marzan]

Merck is doing an investors' call on 6/7 ASCO evening. Could be interesting!